Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 28;14(4):450.
doi: 10.3390/life14040450.

Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review

Affiliations
Review

Ablative Treatments for Small Renal Masses and Management of Recurrences: A Comprehensive Review

Achille Aveta et al. Life (Basel). .

Abstract

This review focuses on ablative techniques for small renal masses (SRMs), including radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and irreversible electroporation (IRE), and discusses recurrence management. Through an extensive literature review, we outline the procedures, outcomes, and follow-up strategies associated with each ablative method. The review provides a detailed examination of these techniques-RFA, CA, MWA, and IRE-elucidating their respective outcomes. Recurrence rates vary among them, with RFA and CA showing comparable rates, MWA demonstrating favorable short-term results, and IRE exhibiting promise in experimental stages. For managing recurrences, various strategies are considered, including active surveillance, re-ablation, or salvage surgery. Surveillance is preferred post-RFA and post-CA, due to slow SRM growth, while re-ablation, particularly with RFA and CA, is deemed feasible without additional complications. Salvage surgery emerges as a viable option for larger or resistant tumors. While ablative techniques offer short-term results comparable to surgery, further research is essential to understand their long-term effects fully. Decisions concerning recurrence management should consider individual and tumor-specific factors. Imaging, notably contrast-enhanced ultrasounds, plays a pivotal role in assessing treatment success, emphasizing the necessity of a multidisciplinary approach for optimal outcomes. The lack of randomized trials highlights the need for further research.

Keywords: RCC; ablative techniques; recurrence; small renal masses.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Treatment options for SRMs. SRMs, small renal masses; RFA, radiofrequency ablation; CA, cryoablation; MWA, microwave ablation; IRE, irreversible electroporation.

References

    1. Bukavina L., Bensalah K., Bray F., Carlo M., Challacombe B., Karam J.A., Kassouf W., Mitchell T., Montironi R., O’Brien T., et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur. Urol. 2022;82:529–542. doi: 10.1016/j.eururo.2022.08.019. - DOI - PubMed
    1. Ljungberg B., Albiges L., Abu-Ghanem Y., Bedke J., Capitanio U., Dabestani S., Fernández-Pello S., Giles R.H., Hofmann F., Hora M., et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur. Urol. 2022;82:399–410. doi: 10.1016/j.eururo.2022.03.006. - DOI - PubMed
    1. Calace F.P., Napolitano L., Arcaniolo D., Stizzo M., Barone B., Crocetto F., Olivetta M., Amicuzi U., Cirillo L., Rubinacci A., et al. Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review. Medicina. 2022;58:1624. doi: 10.3390/medicina58111624. - DOI - PMC - PubMed
    1. Lasorsa F., Rutigliano M., Milella M., Ferro M., Pandolfo S.D., Crocetto F., Autorino R., Battaglia M., Ditonno P., Lucarelli G. Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers. Int. J. Mol. Sci. 2023;24:13179. doi: 10.3390/ijms241713179. - DOI - PMC - PubMed
    1. Lasorsa F., Rutigliano M., Milella M., Ferro M., Pandolfo S.D., Crocetto F., Simone S., Gesualdo L., Battaglia M., Ditonno P., et al. Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma. Int. J. Mol. Sci. 2023;24:16515. doi: 10.3390/ijms242216515. - DOI - PMC - PubMed

LinkOut - more resources